diff --git a/pages/STOP2030___Web___Update 2024___02.md b/pages/STOP2030___Web___Update 2024___02.md
index aa5b39af..c7d64c78 100644
--- a/pages/STOP2030___Web___Update 2024___02.md	
+++ b/pages/STOP2030___Web___Update 2024___02.md	
@@ -86,4 +86,5 @@
 		- ### Background
 			- Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]].
 			- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest [[level]] of investment risk of all candidates for Combinations for [[STH]] treatment (fuente: Soil Transmitted Helminths Drug Combinations Expert Meeting, 2016, Gates Foundation)
-			- El ALIVE study
\ No newline at end of file
+			- El ALIVE trial study: https://gatesopenresearch.org/articles/6-62/v1
+			-
\ No newline at end of file